학술논문
Ponatinib in Refractory Ph-Positive Leukemias: A Phase 2 Trial
Document Type
Academic Journal
Author
Cortes, J E; Kim, D-W; Pinilla-Ibarz, J; le Coutre, P; Paquette, R; Chuah, C; Nicolini, F E; Apperley, J; Khoury, H J; Talpaz, M; DiPersio, J; DeAngelo, D J; Abruzzese, E; Rea, D; Baccarani, M; Müller, M C; Gambacorti-Passerini, C; Wong, S; Lustgarten, S; Rivera, V M; Clackson, T; Turner, C D; Haluska, F G; Guilhot, F; Deininger, M W; Hochhaus, A; Hughes, T; Goldman, J; Shah, N P; Kantarjian, H
Source
The New England Journal of Medicine. Nov 07, 2013 369(19)
Subject
Language
English
ISSN
0028-4793